The Western Blotting Market is predicted to grow at a 6.0% CAGR through 2031. Due to increased scientific and research activities, the market for western blotting products has significantly increased recently. Manufacturers are emphasising the release of a greater range of products in response to the growing demand for various types of electrophoresis blotting systems, …
Category Archives: Healthcare Trends
Advanced Wound Management Market is expected to surpass US$ 11.5 billion by 2033 | FMI Study
The Advanced Wound Management Market is expected to be valued at US$ 8.1 billion in 2023, with FMI forecasting a market valuation of US$ 11.5 billion by 2033. During the forecast period, the market will grow at a CAGR of 3.6%. Increasing cases of chronic ulcers, traumatic injuries, obesity, burn wounds, and sedentary lifestyle propel …
Surface Plasmon Resonance Market is predicted to be valued at US$ 1807.7 million by 2032 | FMI Report
The Surface Plasmon Resonance Market is expected to grow from US$ 910.4 million in 2022 to US$ 1807.7 million in 2032. According to FMI, the market will grow at a 7.1% CAGR during the forecast period. Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability …
Oxygen Therapy Equipment Market in United States is expected to surge at a CAGR of 7.6% by 2032 | FMI Analyst
The Oxygen Therapy Equipment Market is expected to grow at a 7.4% CAGR between 2022 and 2032. The Oxygen Therapy Equipment Market is expected to grow from US$ 3.1 billion in 2022 to US$ 6.4 billion in 2032. “Over the forecast period, the demand is expected to be driven by the rising popularity and adoption …
Hemostatic Gels Market is expected to reach a valuation of US$ 1.9 Billion at a CAGR of 6.8% by 2032 | FMI Study
The Hemostatic Gels Market was valued at US$ 957.1 million in 2021, and by 2032, it is projected to grow at a CAGR of 6.8% to reach US$ 1.9 billion. A recent analysis by Future Market Insights indicates that porcine-based hemostatic gels would dominate the market in 2021 with a market share of about 45%. …
Precision Cancer Imaging Market is expected to grow at a CAGR of 12% by 2032 | FMI Study
The Precision Cancer Imaging Market is expected to grow at a CAGR of 12% during the forecast period, from US$ 67.8 billion in 2022 to US$ 210.58 billion by 2032. Precision cancer imaging system sales are expected to increase as patients become more aware of the molecular basis of cancer and express a preference for …
United States is expected to account for more than 40% of the Biosimulation Market by 2032 | FMI
The global Biosimulation Market was estimated to be worth roughly US$ 2.6 billion in 2021; however, a CAGR of 21.5% is predicted for the following ten years, meaning that by the end of 2032, the market is likely to have grown to be worth US$ 20.9 billion. The need for biosimulation will be driven by …
Age Related Vision Dysfunction Market in North America is expected to grow at a CAGR of 3.6% in the assessment period 2023 to 2033 | FMI Analysis
A recently published study by FMI expects the global Age-Related Vision Dysfunction Market to augment at a 3.7% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 130 Billion is expected for the market. The rising incidence of visual impairment and blindness is a primary driver of …
Idiopathic Pulmonary Fibrosis Management Market is expected to register a CAGR of 1.5% in the forecast period 2023 to 2033 | FMI
During the forecast period 2023 to 2033, the Idiopathic Pulmonary Fibrosis Management Market is expected to grow at a value of 1.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Idiopathic pulmonary fibrosis management is expected to rise up to a market valuation of US$ 3649.90 Million. The growth …
Multiplex Molecular Diagnostics Market to reach the valuation of US$ 39.25 Billion by 2032
[Report of 250 Pages] The multiplex molecular diagnostics market is projected to grow at a CAGR of 5.4% over the course of the forecast period, from an estimated value of US$ 23.2 billion in 2022 to US$ 39.25 billion by 2032. Multiplex Molecular Diagnostics Market: Overview Highly multiplexed molecular diagnostics are powerful tools for patient care, epidemiologic …